Blue Horseshoe Stocks: RKDA Explodes & More

Arcadia Biosciences, Inc. RKDA

We originally put RKDA on our radars toward the end of January, but in the ensuing weeks, the stock mainly traded sideways.

This week, both Tuesday morning and yesterday, we included it on our watchlist once again as we noticed it was finally building up some momentum. Yesterday that momentum turned into an absolute explosion as RKDA blasted off to an astounding new high.

Just since Tuesday morning it has traded from a low of 11.17 to a new high of 54.9895 yesterday. That’s a two day swing of 370% and a mind numbing increase of 1244% over the 4.09 low we observed subsequent to our initial mention!


Valeant Pharma International, Inc. VRX

On Monday morning, we tagged the VRX Weekly $15 & $15.50 Calls, and after finding success with those as VRX continued to move, yesterday we expanded our target range to include the $16 and $16.50′s  as well. After another bullish session, all of those ideas produced opportunities for big gains.

The $15′s from our observed low on Monday of .65, hit 2.21 for a gain of 240%, while the $15.50′s, from .30 reached 1.73, an increase of 477%

The $16 Calls ran from .35-1.24, for a single sessions rip of 254% and the $16.50′s traded in a range from .13 to .75, a 477% upswing.



Fresh Options Idea:

Dollar General Corp. DG Weekly $94-96.50 Calls


Extended Watchlist:
ABCD, ABEO, APRN, APTO, ONCS, EVEP, RUBI, XXII,

Blue Horseshoe Stocks: ECYT Recap & More

Endocyte, Inc. ECYT

Our first order of business this morning is to review the recent performance of ECYT, which we initially slated for observation in our report on February 28th. At the time, the stock had been slowly gaining momentum for much of February, and it looked ripe for a more pronounced breakout.

That day, as the stock was trading for as little as 4.51, we witnessed an explosion in volume that has precipitated a very impressive run, persisting for over two weeks up to the present time. Yesterday’s session brought a new high of 11.54 in ECYT, which marks an upswing of 156% in a relatively short time frame.


Valeant Pharma International, Inc. VRX

On Monday morning, we came up with some options ideas for VRX, which we noted was “ready for a bottom bounce”. We also made reference to a huge Form-4 buy of $108.8M came in as well, which led us to postulate that “for now the stock has gone as low as it’s going to go.”

We couldn’t have been any more spot-on in our assessment of VRX, and the result has been a solid performance for the short-term calls we put on watch, the VRX Weekly $15 & $15.50 Calls. The $15′s ran from .65-1.15 for a gain of 77%, while the $15.50′s moved from a low of .30 to .71, an increase of 137%

We had some longer-term ideas as well which we will likely come back to in an upcoming report, as it appears VRX will continue to head up. On that note, we’ll also look to roll up our strike prices on the weekly calls to the $16 & $16.50′s.

_______________

Fresh Options Idea:

Walmart, Inc. WMT 04/20 $95-97.50 Calls


Extended Watchlist:
RKDA, EXPR, NCTY, VYGR, TYME, MARA

Blue Horseshoe Stocks: More Options Success

SPDR S&P 500 ETF (SPY) – Options Recap
-
Our options calls we made for the SPY on Friday morning were very good to us, and were an excellent way to close out what was ultimately a very successful trading week.

We put a flag up on the SPY Weekly $274.50-277 Calls after seeing the markets stabilize last midweek, following a couple of turbulent sessions as a result of Trump administrations newly announced tariffs. Things looked ripe for a rebound on Friday and that’s just what we got, with the SPY turning in a bullish performance from start to finish.

There were six sets of contracts contained in our designated range, and regardless of which strike price was chosen, intraday gains were on the table, ranging from very good to absolutely fantastic.

$272 Calls – Range: 1.30-4.31 – Max Gain: 232%
$272.50 Calls – Range:  .80-3.90 – Max Gain: 387%
$273 Calls – Range: .68-3.25 – Max Gain: 378%
$273.50 Calls – Range: .46-2.90 – Max Gain: 530%
$273 Calls – Range: .26-2.45 – Max Gain: 842%
$273.50 Calls – Range: .10-1.90 – Max Gain: 1800%

_______

Burlington Stores, Inc. BURL – Speaking of multi-bag options winners, we slated the  BURL 03/16 $120 & $125 Calls for observation on Thursday morning, and those finished out the week with stregth as well. The $120 Calls ran from 4.04-8.50, for an intraday rip of 110%, while the $125 nearly doubled that performance with a 212% run from 1.35-4.21.


Lumentum Holdings, Inc. LITE

We want to swing back around to recap the recent performance of LITE as well. Since our alert on the stock on February 7th, at which time the stock was trading for as little as 52.20/share, LITE has made considerable and steady upward progress.

On Friday it hit a new high of 69.25, marking a move of 33% in less than five weeks. That is quite a feat for a stock that started out above $50!

_______________

Fresh Options Idea:

Valeant Pharma International, Inc. VRX -We’re going to formulate a short and longer-term options idea for VRX, which is looking like it could be ready for a bottom bounce. Last week, an insider buy to the tune of more than $108.8M came in as well, which just reinforces our assumption that for now the stock has gone as low as it’s going to go.

We’ll be looking at the VRX Weekly $15 & $15.50 Calls, as well as the 04/13 $16 & $16.50 Calls.


Extended Watchlist:
ADMS, AKER, CPST, KANG, MRTX, NPTN, ENRJ

Blue Horseshoe Stocks: SNAP Review & More

Snap, Inc. SNAP – Options Idea

After a mixed bag of news yesterday that included a 12% stake being bought in SNAP by China’s Tencent Holdings, and a poor quarterly earnings report, we signaled our interest in tracking the  SNAP Weekly $15-14 Puts for quick strike trades.

It turned out to be a good idea as the stock gapped down and continued to plunge, sending our observed contracts hurtling upward.

$15 Puts – Range: 1.10-2.85 – Max Gain: 159%
$14.50 Puts – Range: .76-2.30 – Max Gain: 203%
$14 Puts – Range: .50-1.89 – Max Gain: 278%


Valeant Pharmaceuticals International, Inc. VRX – Options Update

We began tracking the VRX Weekly $13-14 Calls on Tuesday morning, and saw some pretty nice moves out of them early on in that session.

With the help of another, even more bullish session we were able to see our observed ranges on the specified contracts extended by a considerable margin. The following table represents Tuesday’s lows to yesterday’s highs, and the two-day, multi-bag gains that were possible.

$13 Calls – Range: .82-2.28 – Max Gain: 178%
$13.50 Calls – Range: .52-1.75 – Max Gain: 237%
$14 Calls – Range: .28-1.30 – Max Gain: 364%


Fresh Options Idea: AT&T, Inc. T

We’ve had our eye on AT&T for awhile as it was recently searching out a bottom, waiting for the proper time to pounce with a potential recovery play. Over the past couple of sessions, the stock has establish a solid base of support and begun to try to come up off of those lows, which are the lowest of the year so far.

We’re going to be looking after the T 01/19 $34-36 Calls for a longer-term rebound play, in the days and weeks ahead.


Extended Watchlist:
NPTN, KBSF, UUUU, COTY, DNN, PRTY, SAGE, ENRJ

Blue Horseshoe Stocks: Cannabis Commentary & More

NeoPhotonics Corp. NPTN

We’re always bargain hunting for stocks that have been recently beaten back to what appear to be unsustainably low levels, and we’re observing one heck of a double bottom setup on NPTN at the present time.

Twice now the stock has touched and rebounded off of the mid-$4 range, with the annual low coming in at 4.56. We’re going to want to place NPTN on watch in sessions to come and look for the stock to establish higher levels of support.



Valeant Pharmaceuticals International, Inc. VRX

It’s been awhile since we had a look at VRX, and as it turns out, this is another stock that looks ready to start a trend off of a recent relative low.

VRX is gapping up considerably into the $14-range this morning on the heels of a solid earnings beat. We’re going to signal a range of options contracts to watch for some possible dip-and-rip activity. This is just the type of setup we routinely look for, and we’ll be tracking the VRX Weekly $13-14 Calls for the remainder of the week.



Cannabis Commentary

It has been a slow year in general for many domestic cannabis stocks, due, at least in part, to a DOJ led by outspoken marijuana opponent Jeff Sessions. It has created an environment of uncertainty pertaining to the federal government’s likelihood of creating problems for marijuana businesses, even in states where voters have officially spoken and legalized the plant. The marijuana movement is here to stay, but at present, is dealing with this roadblock of sorts.

That doesn’t mean our interest in the sector has diminished. In fact, we’re as exuberant about the future of the cannabis industry as we ever were. North of the Border, Canadians will enact a nationwide end to prohibition just 8 months from now.

The World Anti-Doping Agency, which was formed by the International Olympic Committee to police the use of performance enhancing drugs in athletics, also recently removed Cannabidiol (CBD) from its list of banned substances, opening up a huge market for the hemp-derived product.

Here are just a few of the cannabis plays that we track on a regular basis, and will continue to do so as we head into 2018, which we feel is going to be a big year for the industry and all of its subsectors. Maybe the biggest one yet!

MJNA, TRTC, MJTK, AGTK, GRNH, HEMP, ACBFF, APHQF,  TWMJF, CBIS, XXII,


Extended Watchlist:
TXMD, EVEP, DXTR, COLL, CRC